In8bio

INABNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$10.844 M

$1.10 -3.51%

Close of 23 Sept 2026

Revenue

—

Not reported

Earnings

-$19.4M

Loss-making

Shares outstanding

9,858,383

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#146Intensity TherapeuticsINTS$13.4M
#147PluriPLUR$13.1M
#148In8bioINAB$10.8M
#149Senti BiosciencesSNTI$10.5M
#150Black TitanBTTC$7.52M

What if In8bio were worth as much as…

Open the what-if tool →

Gold $29.8T

$3,027,568

Per share 2,752,335× higher

Bitcoin $1.69T

$171,845.67

Per share 156,223× higher

Nvidia $5.43T

$551,286.27

Per share 501,169× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for In8bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.